Physician profile
Nam Vo
NPI 1821988783
$585.16
in general payments reported to CMS, 2019-2025
8 companies · $585 in 2025
The $585 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $585.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $585.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $142.87 | 2025 | Evoke |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $101.09 | 2025 | Relistor |
| Tonix Medicines, INC. | $94.25 | 2025 | Tonmya |
| Pfizer INC. | $83.20 | 2025 | |
| Axsome Therapeutics, INC. | $63.07 | 2025 | Symbravo |
| Spinal Simplicity, LLC | $43.37 | 2025 | Ha Minuteman G3-R |
| Collegium Pharmaceutical, INC. | $37.91 | 2025 | Belbuca |
| Medtronic, INC. | $19.40 | 2025 | Inceptiv |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nam Vo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.